Article Information
History
- June 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kara L Lynch1,*,
- Jeffrey D Whitman1,
- Noreen P Lacanienta1,
- Erica W Beckerdite1,
- Shannon A Kastner1,
- Brian R Shy1,
- Gregory M Goldgof1,
- Andrew G Levine1,
- Sagar P Bapat1,
- Susan L Stramer2,
- Jonathan H Esensten1,
- Allen W Hightower3,
- Caryn Bern4 and
- Alan HB Wu1
- 1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Scientific Affairs, American Red Cross, Gaithersberg, MD, USA
- 3Independent consultant, Bangkok, Thailand
- 4Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, San Francisco, CA, USA
- ↵* Correspondence to: Kara L. Lynch, PhD, University of California, Department of Laboratory Medicine, 1001 Potrero Ave. Bldg. 5 2M16, San Francisco, CA 94110, Phone: 628-206-5477, Email: kara.lynch{at}ucsf.edu
Posted June 09, 2020.
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity
